The company engaged in manufacturing and sales of enzymes business had profit of Rs 19.91 crore in the year ago quarter.
Net sales of the company during quarter under review was down 18.9% YoY at Rs 60 crore against Rs 74.4 crore in the corresponding quarter of previous fiscal.
Meanwhile, the board has approved the sub-division of face value of share capital of the company from existing Rs 10 per share to Rs 2 per share.
At 02:35 pm; the stock was down 8% at Rs 1,658 on the BSE as compared to 0.06% decline in the S&P BSE Sensex. The trading volumes on the counter jumped multiple folds with a combined 753,363 shares changed hands on the BSE and NSE so far.
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
-
Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
-
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in